Status:
COMPLETED
Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration
Lead Sponsor:
Pfizer
Conditions:
Macular Degeneration
Age-related Macular Degeneration
Eligibility:
All Genders
18+ years
Brief Summary
Long-term observational study to assess the safety, efficacy and quality of life of patients with neovascular age-related macular degeneration (AMD) under Macugen treatment.
Detailed Description
Ophthalmologists who are experienced in doing intravitreal injections in Germany
Eligibility Criteria
Inclusion
- patients with neovascular age-related macular degeneration
Exclusion
- none
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
1001 Patients enrolled
Trial Details
Trial ID
NCT01245387
Start Date
August 1 2006
End Date
December 1 2009
Last Update
January 13 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.